KRAS is the most frequently mutated oncogene in cancers, with mutation rates of up to 96% in pancreatic cancers [7, 8], 54% in colorectal cancers (CRC) [9, 10], and 39% in lung adenocarcinomas [11]. Here, KRAS is linked to cancer.